• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Breast carcinoma-amplified sequence 4 (BCAS4)

ACP13016

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP13016 Target NameBCAS4
Target SynonymsBCAS4Breast carcinoma-amplified sequence 4FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-211
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ8TDM0
Background Information
  • Uniprot Id

    Q8TDM0

  • Target Species

    Human

  • Target Name

    BCAS4

  • Target Full Name

    Breast carcinoma-amplified sequence 4

  • Target Involvement

    A chromosomal aberration involving BCAS4 has been found in some breast carcinoma cell lines. Translocation t(17;20)(q23;q13) with BCAS3.

  • Target Subcellular Location

    Cytoplasm.

  • Target Protein Families

    Cappuccino family

  • Target Tissue Specificity

    Brain, thymus, spleen, kidney and placenta. Overexpressed in most breast cancer cell lines.

  • Target Synonyms

    BCAS4Breast carcinoma-amplified sequence 4

Inquire Recombinant Human Breast carcinoma-amplified sequence 4 (BCAS4) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification